{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:52:29Z","timestamp":1795110749858,"version":"4.10.3"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ijgc-2021-002530","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T05:30:11Z","timestamp":1646631011000},"page":"332-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Definitive chemoradiation or radiation therapy alone for the management of vulvar cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Parul Nafees","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002530_bb0010","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2021-002530_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0360-3016(98)00193-X","article-title":"Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group","volume":"42","author":"Moore","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002530_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2011.11.003","article-title":"A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"124","author":"Moore","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0025","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/1097-0142(19841115)54:10<2056::AID-CNCR2820541003>3.0.CO;2-L","article-title":"Preoperative radiation therapy for locally advanced vulvar cancer","volume":"54","author":"Hacker","year":"1984","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002530_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000421-198704000-00055","article-title":"Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer","volume":"10","author":"Boronow","year":"1987","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2007.10.026","article-title":"Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma","volume":"109","author":"Beriwal","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0040","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2020.09.019","article-title":"Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?","volume":"159","author":"Richman","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2019.11.027","article-title":"High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: outcome and toxicity","volume":"156","author":"Rishi","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.adro.2017.02.006","article-title":"Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes","volume":"2","author":"Rao","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2021.01.003","article-title":"Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer","volume":"161","author":"Ashmore","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IGC.0000000000000938","article-title":"Primary versus preoperative radiation for locally advanced vulvar cancer","volume":"27","author":"Natesan","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002530_bb0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ygyno.2017.06.022","article-title":"Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: a review of the National Cancer Database","volume":"146","author":"Rao","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0070","first-page":"733","article-title":"Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes","volume":"68","author":"Homesley","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2021-002530_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","article-title":"Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2021-002530_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0360-3016(92)90699-I","article-title":"Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study","volume":"24","author":"Stehman","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002530_bb0085","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/1097-0142(19950501)75:9<2286::AID-CNCR2820750916>3.0.CO;2-G","article-title":"The variation of inguinal lymph node depth in adult women and its importance in planning elective irradiation for vulvar cancer","volume":"75","author":"McCall","year":"1995","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002530_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2015.09.077","article-title":"Sentinel nodes in vulvar cancer: long-term follow-up of the Groningen International study on sentinel nodes in vulvar cancer (GROINSS-V) I","volume":"140","author":"Te Grootenhuis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0095","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.21.00006","article-title":"Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II","volume":"39","author":"Oonk","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2014.08.009","article-title":"Inguinal nodal region radiotherapy for vulvar cancer: are we missing the target again?","volume":"135","author":"Glaser","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.prro.2011.12.005","article-title":"Contouring inguinal and femoral nodes; how much margin is needed around the vessels?","volume":"2","author":"Kim","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0110","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002530_bb0115","author":"McMillian","year":"2021","journal-title":"NCCN guidelines version 3.2021 vulvar cancer (squamous cell carcinoma)"},{"key":"10.1136\/ijgc-2021-002530_bb0120","author":"NRG Oncology","year":"2020","journal-title":"A phase II trial evaluating cisplatin (NSC #119875) and gemcitabine (NSC #613327) concurrent with intensity-modulated radiation therapy (IMRT) in the treatment of locally advanced squamous cell carcinoma of the vulva"},{"key":"10.1136\/ijgc-2021-002530_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2018.01.007","article-title":"Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy","volume":"148","author":"Stecklein","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ygyno.2014.12.013","article-title":"Survival outcomes for patients with stage IVb vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?","volume":"136","author":"Thaker","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0135","doi-asserted-by":"crossref","first-page":"922","DOI":"10.6004\/jnccn.2019.7288","article-title":"Role of locoregional treatment in vulvar cancer with pelvic lymph node metastases: time to reconsider FIGO staging?","volume":"17","author":"Shinde","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2021-002530_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2020.07.2599","article-title":"PET-CT directed IMRT-based chemoradiation for locally advanced vulvar cancer - analysis of regional recurrence patterns","volume":"108","author":"Ling","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002530_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2018.08.002","article-title":"Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy","volume":"151","author":"Horne","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0155","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-Ddse radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0160","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/14712598.2018.1542426","article-title":"The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy","volume":"18","author":"Abdulrahman","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1136\/ijgc-2021-002530_bb0165","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.19.00739","article-title":"Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I\/II CheckMate 358 trial","volume":"37","author":"Naumann","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.radonc.2016.12.019","article-title":"Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva","volume":"122","author":"Rao","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2021-002530_bb0175","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ijrobp.2012.11.012","article-title":"Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse","volume":"85","author":"Beriwal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:40:31Z","timestamp":1753224031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1048891X24006030"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002530","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive chemoradiation or radiation therapy alone for the management of vulvar cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}